New FDA Rules Aim to Make Drug Ads Clearer: Are They Enough?

Bookmark Article



Bookmark Article


On “What’s Trending,” hosts Jessica Reyes, Patricia Wu, and guest MHTN Chief Medical Officer Dr. Dan Bober discuss a major change coming to drug advertising starting in May.

Side effects in plain sight

The FDA wants to end the practice of quickly rattling off risks in drug commercials, ensuring patients can truly understand them.

Focus on what matters

Dr. Bober recommends focusing on the most common and most serious side effects of a medication, rather than an overwhelming list.

Will the change be effective? 

It’s unclear how strictly the new FDA rule will be enforced and whether it will significantly impact how drug ads are perceived.

Editorial Team
Editorial Team
At the heart of MHTN - America's pioneering 24/7 Mental Health TV Network - is our editorial team, a dynamic group of professionals united by a shared commitment to transforming the conversation around mental health. Our team is composed of seasoned journalists, mental health experts, researchers, and storytellers, each bringing a wealth of experience and a passion for advocacy.


Please enter your comment!
Please enter your name here

Read more


Related Articles